» Articles » PMID: 37650112

Derivation and Elimination of Uremic Toxins from Kidney-gut Axis

Overview
Journal Front Physiol
Date 2023 Aug 31
PMID 37650112
Authors
Affiliations
Soon will be listed here.
Abstract

Uremic toxins are chemicals, organic or inorganic, that accumulate in the body fluids of individuals with acute or chronic kidney disease and impaired renal function. More than 130 uremic solutions are included in the most comprehensive reviews to date by the European Uremic Toxins Work Group, and novel investigations are ongoing to increase this number. Although approaches to remove uremic toxins have emerged, recalcitrant toxins that injure the human body remain a difficult problem. Herein, we review the derivation and elimination of uremic toxins, outline kidney-gut axis function and relative toxin removal methods, and elucidate promising approaches to effectively remove toxins.

Citing Articles

Probiotic interventions in peritoneal dialysis: A review of underlying mechanisms and therapeutic potentials.

Stepanova N World J Nephrol. 2024; 13(4):98719.

PMID: 39723354 PMC: 11572655. DOI: 10.5527/wjn.v13.i4.98719.


Renoprotective effects of empagliflozin in high-fat diet-induced obesity-related glomerulopathy by regulation of gut-kidney axis.

Lei L, Zhu T, Cui T, Liu Y, Hocher J, Chen X Am J Physiol Cell Physiol. 2024; 327(4):C994-C1011.

PMID: 39183639 PMC: 11481992. DOI: 10.1152/ajpcell.00367.2024.


Analysis of the microecological mechanism of diabetic kidney disease based on the theory of "gut-kidney axis": A systematic review.

Huang L, Wu W, Wang X Open Life Sci. 2024; 19(1):20220909.

PMID: 39119482 PMC: 11306963. DOI: 10.1515/biol-2022-0909.


Uremic Stomatitis: A Latin American Case Series and Literature Review.

de Arruda J, Monteiro J, Barreto M, Villarroel-Dorrego M, Gilligan G, Panico R Head Neck Pathol. 2024; 18(1):54.

PMID: 38896178 PMC: 11187249. DOI: 10.1007/s12105-024-01652-3.


Gut-Kidney-Heart: A Novel Trilogy.

Caldarelli M, Franza L, Rio P, Gasbarrini A, Gambassi G, Cianci R Biomedicines. 2023; 11(11).

PMID: 38002063 PMC: 10669427. DOI: 10.3390/biomedicines11113063.

References
1.
Su P, Lee Y, Kuo L, Chen Y, Chen C, Kang Y . Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials. Front Pharmacol. 2021; 12:676345. PMC: 8350440. DOI: 10.3389/fphar.2021.676345. View

2.
Hsu C, Hou C, Chang C, Tain Y . Resveratrol Butyrate Ester Protects Adenine-Treated Rats against Hypertension and Kidney Disease by Regulating the Gut-Kidney Axis. Antioxidants (Basel). 2022; 11(1). PMC: 8772985. DOI: 10.3390/antiox11010083. View

3.
Gryp T, Vanholder R, Vaneechoutte M, Glorieux G . p-Cresyl Sulfate. Toxins (Basel). 2017; 9(2). PMC: 5331431. DOI: 10.3390/toxins9020052. View

4.
Kawazoe Y, Sato T, Miyagawa N, Yokokawa Y, Kushimoto S, Miyamoto K . Mortality Effects of Prolonged Hemoperfusion Therapy Using a Polymyxin B-Immobilized Fiber Column for Patients with Septic Shock: A Sub-Analysis of the DESIRE Trial. Blood Purif. 2018; 46(4):309-314. DOI: 10.1159/000491744. View

5.
Nagata D, Yoshizawa H . Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease. Int J Nephrol Renovasc Dis. 2020; 13:359-365. PMC: 7726832. DOI: 10.2147/IJNRD.S287237. View